Lara M. Mangravite, Ph.D.
Affiliations: | 2002 | University of California, San Francisco, San Francisco, CA |
Area:
Pharmaceutical Chemistry, Pharmacology, Cell BiologyGoogle:
"Lara Mangravite"Parents
Sign in to add mentor| Kathleen M. Giacomini | grad student | 2002 | UCSF | |
| (Localization and sorting of nucleoside transporters in the kidney.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Allen M, Carrasquillo MM, Funk C, et al. (2016) Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases. Scientific Data. 3: 160089 |
| Yu CY, Theusch E, Lo K, et al. (2014) HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism. Human Molecular Genetics. 23: 319-32 |
| Mangravite LM, Engelhardt BE, Medina MW, et al. (2013) A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature. 502: 377-80 |
| Brown CD, Mangravite LM, Engelhardt BE. (2013) Integrative Modeling of eQTLs and Cis-Regulatory Elements Suggests Mechanisms Underlying Cell Type Specificity of eQTLs Plos Genetics. 9 |
| Oshiro C, Mangravite L, Klein T, et al. (2010) PharmGKB very important pharmacogene: SLCO1B1. Pharmacogenetics and Genomics. 20: 211-6 |
| Welsh M, Mangravite L, Medina MW, et al. (2009) Pharmacogenomic discovery using cell-based models. Pharmacological Reviews. 61: 413-29 |
| Erdman AR, Mangravite LM, Urban TJ, et al. (2006) The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. American Journal of Physiology. Renal Physiology. 290: F905-12 |
| Shu Y, Leabman MK, Feng B, et al. (2004) PharmGKB update: III. Genetic variants of SLC22A1, solute carrier family 22 (organic cation transporter), member 1. Pharmacological Reviews. 56: 161 |
| Gray JH, Mangravite LM, Owen RP, et al. (2004) Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations. Molecular Pharmacology. 65: 512-9 |
| Mangravite LM, Badagnani I, Giacomini KM. (2004) Corrigendum to “Nucleoside transporters in the disposition and targeting of nucleoside 2 analogs in the kidney” [Eur. J. Pharmacol. 479/1–3 (2003) 269–281] European Journal of Pharmacology. 486: 239 |